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Key messages
What is already known about this subject?
 ► Different types of organisational changes at 
work may have different negative effects on 
stress-related prescriptions for psychotropic 
medication among male and female employees.
What are the new findings?
 ► Organisational changes in the workplace were 
associated with higher risk of prescription for 
psychotropic medication in the following year 
relative to no change in the workplace.
 ► This association was particularly strong for 
exposure to change in management and 
prescriptions for antidepressants, but results 
did not vary by sex or previous history of 
psychotropic medication prescription.
 ► Splitting the 12-month follow-up period into 
two halves yielded the strongest effects during 
the latter period after different types of change, 
suggesting a latency period before excess use 
of psychotropic medication.
 ► Factors at the work-unit level accounted for 
6% of the total variance in prescriptions for 
psychotropic medication, indicating that this 
level is an important contributor to use of 
psychotropic medication among employees.
How might this impact on policy or clinical 
practice in the foreseeable future?
 ► Decision-makers and policy-makers should 
consider that different types of organisational 
change in the workplace may pose risks for 
employee mental health.
AbsTrACT
Objectives We examined exposure to different types 
of organisational changes at work as risk factors for 
subsequent prescription for psychotropic medication 
among employees.
Methods the study population included 15 038 public 
healthcare employees nested within 1284 work units in 
the capital region of Denmark. Multilevel mixed-effects 
parametric survival models were developed to examine 
time to prescription for psychotropic medications 
(anxiolytics/hypnotics/sedatives/antidepressants) 
during the 12-month interval following exposure to 
organisational changes relative to no change from 
January to December 2013. Data on work-unit level 
organisational changes (including mergers, split-ups, 
relocation, change in management, employee lay-
offs and budget cuts) were collected from work-unit 
managers (59% response).
results any organisational change versus no change 
was associated with a higher risk of psychotropic 
prescription (Hr: 1.14, 95% ci: 1.02 to 1.26), especially 
change in management (Hr: 1.23, 95% ci: 1.07 to 
1.41). Splitting the 12-month follow-up period into two 
halves yielded particularly high rates of psychotropic 
prescription in the latter half of the follow-up, for 
example, any change (Hr: 1.25, 95% ci: 1.11 to 1.41), 
change in management (Hr: 1.42, 95% ci: 1.22 to 1.65), 
mergers (Hr: 1.26, 95% ci: 1.06 to 1.50), employee 
lay-off (Hr: 1.23, 95% ci: 1.03 to 1.46) and budget cuts 
(Hr: 1.13, 95% ci: 1.00 to 1.41). the associations did 
not vary by sex.
Conclusions Organisational changes in the workplace, 
especially change in management, may be associated 
with increased risk of psychotropic prescription among 
employees regardless of sex.
InTrOduCTIOn
Depressive and anxiety disorders are estimated to 
be the third and ninth leading causes, respectively, 
of disability globally.1 Most people spend many 
of their waking hours in an occupational setting, 
and workplace conditions thus play a key role for 
employee well-being. Organisational changes in the 
workplace (eg, downsizing or mergers) are often 
implemented as a strategy to maximise competitive-
ness in a globalised economy.2 3
Organisational changes at work seem to have 
adverse impacts on employee health and well-
being.4–8 Although evidence supports an association 
between individual reporting of higher psychosocial 
stress and excess risk of depression,9 anxiety10 11 and 
disturbed sleep,12 longitudinal associations between 
organisational changes and stress-related clinical 
psychiatric disorders remain unclear.13
Some studies found excess self-reported psychi-
atric symptoms following changes including 
downsizing and mergers,14–17 but inconsistent 
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findings have also been reported.13 18 Negative appraisals of 
mergers has been linked to 1.60-fold higher risk of a psychi-
atric event19; however, this association may likely be inflated 
due to underlying negative affectivity influencing both expo-
sure and outcome.20 Another study found 1.03–1.16-fold 
higher relative risk of total sickness absence for ≥2 simul-
taneous change types, mergers, change in management and 
budget cuts,5 suggesting that employees react differently to 
different change types.21
Studies on organisational changes and prescriptions for 
psychotropic medication22–25 mainly focused on major company 
downsizing (≥18% staff reduction) to find associations with 
higher relative risk of psychotropic prescriptions.22–24 Associa-
tions stratified by sex showed similar patterns of prescriptions 
in Swedish studies,23 24 with higher relative risk for prescrip-
tions among male employees (RR: 1.49, 95% CI: 1.10 to 
2.02) compared with female employees (RR: 1.12, 95% CI: 
1.00 to 1.27) in the Finnish study.22 This sex difference could 
be due to greater job demands and lower social support among 
men.26
A Danish study on company changes targeting specific 
dimensions showed that changes regarding cooperation/coor-
dination and, especially, those targeting multiple dimensions 
were associated with higher prescription rates,25 suggesting 
a cumulative effect of multiple changes. These prescrip-
tion effects were stronger in the first year than the 2-year 
period after changes. No associations were found for changes 
targeting effectiveness, adaptation/turbulence or skill/knowl-
edge enhancement.25
Indeed, these prior studies of organisational changes and 
psychotropic prescriptions may be subject to exposure misclassi-
fication (ie, employees not experiencing the changes personally) 
since change data were defined at the company level. Also, none 
of the studies used multilevel modelling to account for poten-
tial clustering of psychotropic prescriptions within the organisa-
tional structure of workplaces27 which may elevate risk of type-I 
error.28
The literature highlights organisational changes as a heter-
ogenous short-term risk factor for clinical mental health prob-
lems among employees since specific and multiple simultaneous 
changes seem to be associated with higher risk of psychotropic 
prescriptions in the years closer to the change event. Sex differ-
ences in this association remain unclear although some evidence 
suggest more adverse effects among men. To better understand 
and potentially mitigate development of negative employee 
effects of organisational changes, there is a need to examine the 
short-term associations between objective measures of specific 
change types and prescriptions for psychotropic medication 
accounting for multilevel clustering.
This study contributes to the literature by using multilevel 
modelling to investigate the putative associations between specific 
types of work-unit organisational changes and excess rates of 
prescription for psychotropic medication among employees 
during the subsequent year. We hypothesised excess prescrip-
tion rates to vary immediately after specific types of organisa-
tional change. Stronger cumulative prescription effects were 
expected after multiple simultaneous changes. Also, we hypoth-
esised more adverse change effects on psychotropic prescriptions 
among males relative to females. We examined these potential 
sex differences in terms of both additive (ie, absolute risk) and 
multiplicative interaction between changes and males (ie, rela-
tive risk) since these two types of interaction may be observed 
independently.29
MeTHOds
study design, data sources and population
We examined the prospective association between exposure 
to work-unit organisational changes during the observation 
period through 2013 and prescription of psychotropic medi-
cation during the ensuing 12-month follow-up period among 
employees (between 1 January 2014 (baseline) and 31 December 
2014). All participants were part of the ongoing Well-being 
in Hospital Employees cohort study.30 The source popula-
tion included all 37 720 healthcare employees nested in 2696 
work units from 14 institutions comprising the capital region 
of Denmark. A work unit was defined as a group of employees 
referring to same immediate manager. Data on organisational 
changes were gathered April–June 2016 via a survey distributed 
to all managers of these work units (59% response). Complete 
data on occupational/sociodemographic information at baseline 
and prescription of psychotropic medication from 2011 to 2014 
were extracted via linkage to company and national registers, 
respectively.
Eligible employees (n=25 897) nested in 2318 work units 
at baseline were identified based on the following inclusion 
criteria: working in work units with ≥3 employees, ≥1 year of 
seniority in the same work unit, ≥18.5 weekly working hours 
throughout 2013, not working multiple positions, not working 
in Denmark or aged ≥18. We allowed for >1 year of seniority 
in a work unit changing name during the observation period of 
organisational changes by including employees if >3 co-workers 
and >30% of the work-unit staff remained in the work unit after 
the name change. These criteria were applied in keeping with a 
previous approach.5 31 We excluded 10 859 eligible employees 
with missing data on organisational changes. The study popu-
lation comprised 15 038 employees nested in 1284 work units 
(figure 1).
There were no significant differences between the source popu-
lation, eligible employees and the study population regarding sex 
composition (p=0.15) or prescriptions for psychotropic medi-
cation (p=0.62) as indicated by χ² tests. Nurses were slightly 
overrepresented in the groups of eligible and studied employees 
(43%) relative to the source population (41%), whereas medical 
doctors/dentists were somewhat under-represented among 
eligible (11%) and studied employees (10%) compared with the 
source population (14%) (p<0.001).
Work-unit level organisational changes
We collected data on exposure to different types of organisational 
changes at the work-unit level by administering a questionnaire 
via working email to all work-unit managers from April to June 
2016. The managers provided information on occurrence of the 
following specific types of organisational changes in their work 
unit for each semester during 2013, viz, mergers, split-ups, relo-
cation, change in management, employee lay-off or budget cuts. 
Responses for 2013 were collapsed because we did not collect 
information on when the changes were announced or initiated 
within the company. We created seven change-indicator vari-
ables at the work-unit level: six variables for each of the types 
of organisational changes and one variable for ‘any changes’ 
(yes/no change). None of the individual types of changes were 
completely overlapping as co-occurrence rates were ≤56% 
(online supplementary material 1).
employee-level prescriptions for psychotropic medication
For outcome purposes, we used information from 1 January to 
31 December 2014 on the date of psychotropic prescriptions 
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Figure 1 Flow of the study population and study design. employees could fulfil multiple exclusion criteria. 
including anxiolytics (WHO Anatomical Therapeutic Chem-
ical (ATC) code: N05B), hypnotics/sedatives (N05C) and anti-
depressants (N06A). These data were used regardless of the 
prescribed daily dose or period for intended use. Although 
follow-up data on psychotropic prescriptions in 2015 were 
available, we did not use these because we presumed that 
psychotropic prescriptions in 2015 would be highly impacted 
by organisational changes in 2014, on which we had no 
information.
employee and work-unit level covariates
We used the following employee-level variables as a priori 
covariates: age, sex, occupational group, manager, personal 
gross income, fixed weekly working hours, contractual employ-
ment, years of seniority and days of sickness absence in 2012. 
We did not consider prior psychotropic prescriptions to be a 
potential confounder because we presumed no causal impact of 
employee-level psychotropic prescriptions on subsequent work-
unit organisational changes.
As work-unit level a priori covariates, we used the number 
of employees within the work unit and selected types of 
organisational changes confounding other types of changes 
(online supplementary material 2). For example, we regarded 
work-unit mergers and split-ups as confounders for the 
relation between change in management and psychotropic 
prescriptions. All covariates were categorical variables 
(table 1).
statistical analysis
We estimated HR and 95% CI using multilevel mixed-effects 
parametric survival models to study the association between 
organisational changes in 2013 and psychotropic prescrip-
tions in 2014. Employees (level 1) were nested within work 
units (level 2). Analyses were unable to converge in three-
level models nesting work units within institutions. Employees 
were followed from 1 January 2014 to the first psychotropic 
prescription (event), death (censoring) or end of study by 31 
December 2014, whichever came first. The relative impact of 
each change-indicator variable (adjusted for other changes as 
appropriately) were evaluated in separate models.
Parametric survival models follow a specified distribution 
from which residual variance at multiple levels is estimated. In 
a null model, residual variance at the work-unit level reflects 
the relative importance of any work-unit factors for psycho-
tropic prescriptions among employees. We fitted a Weibull 
distribution to the survival models as we expected the hazard 
of psychotropic prescriptions to either increase or decrease 
during follow-up32 since the magnitude and exact date of 
the change announcements were unclear. We applied Accel-
eration Failure Time parametrisation for the Weibull models 
which allows for estimation of the intraclass correlation coef-
ficient (ICC) for work units.33 We interpreted  ICC ∗ 100 as 
the proportion of any work-unit factors—observed and unob-
served—explaining the total variance in psychotropic prescrip-
tions among employees.
A four-step sequential modelling strategy with incremental 
adjustment for covariates was used to assess confounding and 
variation in prescriptions explained by the work-unit level 
(online supplementary material 3).
We analysed the association between any changes and 
each subgroup of psychotropic medication (ie, anxiolytics, 
hypnotics/sedatives and antidepressants) first prescribed in 
2014 to assess their relative importance. Sex differences in 
change effects on psychotropic prescriptions were evaluated 
in additive interaction analysis (ie, combined effect) by calcu-
lating the synergy index (S)34 and 95% CI35 as well as in multi-
plicative interaction analysis by including an interaction term 
between indicator variables of any change and male adjusted 
for the separate main effects of change and sex. We estimated 
additive interaction between any changes and females since 
we were unable to calculate 95% CI to S for any changes and 
males (online supplementary material 4).
sensitivity analyses
We reran the analysis for any changes and psychotropic prescrip-
tions during 2014 additionally adjusting for potential confounding 
 o
n
 O
ctober 8, 2020 by guest. Protected by copyright.
http://oem
.bmj.com/
O
ccup Environ M
ed: first published as 10.1136/oem
ed-2018-105442 on 7 January 2019. Downloaded from
 
146 Jensen JH, et al. Occup Environ Med 2019;76:143–150. doi:10.1136/oemed-2018-105442
Workplace
Table 1 The two-level data structure and distribution of variables for the study population and employees/work units exposed to any 
organisational changes
Categories study population, n (% of n) exposed to any changes, n (% of n)
Level 1: employees, N 15 038 (100) 8242 (55)
  Prescription for psychotropic medication 
in 2014
1616 (11) 931 (11)
  Days to first prescription, M (SD) 107 (101) 109 (103)
  Age group 19–40* 3821 (25) 2093 (25)
40–48 3780 (25) 2056 (25)
48–56 3728 (25) 2027 (25)
56–75 3709 (25) 2066 (25)
  Sex Female* 11 507 (77) 6299 (76)
Male 3531 (23) 1943 (24)
  Occupational group Nurses* 6534 (43) 3682 (45)
Medical doctors/dentists 1464 (10) 758 (9)
Social/healthcare workers 1966 (13) 1055 (13)
Pedagogical workers 401 (3) 217 (3)
Service/technical workers 1864 (12) 975 (12)
Administration workers 2809 (19) 1555 (19)
  Seniority, years 1–4* 3125 (21) 173 (21)
5–10 3818 (25) 2076 (25)
11–20 4097 (27) 2239 (27)
21≤ 3998 (27) 2197 (27)
  Manager No* 14 040 (93) 7591 (92)
Yes 998 (7) 651 (8)
  Weekly working hours 18.5–32* 2662 (18) 1511 (18)
32–37 3643 (24) 2023 (25)
37≤ 8733 (58) 4708 (57)
  Contractual employment No* 1066 (7) 487 (6)
Yes 13 972 (93) 7755 (94)
  Personal gross income, DKK ≤345 000* 4427 (29) 2458 (30)
345 000–400 000 3862 (26) 2124 (26)
400 000–480 000 3471 (23) 1852 (22)
≥480 000 3278 (22) 1808 (22)
  Sickness absence in 2012, days No days* 4132 (27) 2274 (28)
1–3 3242 (22) 1760 (21)
4–6 2292 (15) 1271 (15)
7–13 2877 (19) 1517 (18)
≥14 2495 (17) 1420 (17)
Level 2: work units, N 1284 (100)
  Organisational changes No changes* 642 (50)
Any changes 642 (50)
Mergers 195 (15)
Split-ups 75 (6)
Relocation 157 (12)
Change in management 294 (23)
Employee lay-off 245 (19)
Budget cuts 191 (15)
  Number of employees within work unit 3–12* 654 (51) 283 (44)
13–22 306 (24) 164 (26)
23–32 198 (15) 116 (18)
33–142 126 (10) 79 (12)
*Reference category.
DKK, Danish Krone; M, mean.
by prior psychotropic prescriptions between 2011 and 2012 
(ie, preceding changes that occurred in 2013) to evaluate 
confounding by prior psychotropic prescriptions. To assess if the 
association between change in management and psychotropic 
prescriptions was driven by (eg, laid-off) managers, we reran 
this analysis excluding all managers (n=14 040) for compar-
ison with the analysis on the total study population. Associa-
tions with prescriptions through 2014 were analysed according 
to any changes in each semester of 2013 to evaluate possible 
temporality in change exposure. Finally, we analysed exposure 
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to 1, 2 or 3≤ types of simultaneous changes compared with no 
changes to explore the potential cumulative effect on psycho-
tropic prescriptions.
We used a significance level of 0.05 throughout. All statistical 
analyses were conducted using STATA V.14.2 software.
resulTs
Table 1 presents the hierarchical data structure and distribution 
of employee- and work-unit level variables for the study popu-
lation (n=15 038) and among employees/work units exposed 
to any organisational changes (n=8242). The study population 
predominantly comprised female employees, nurses, employees 
with ≥37 weekly working hours (ie, full-time employment). 
Employees with prior psychotropic prescriptions between 
2011 and 2012 were similarly distributed in the study popu-
lation (14%, n=2049) and among employees exposed to any 
changes (14%, n=1173), indicating no confounding by prior 
psychotropic prescriptions. Among the study population, 1616 
employees (11%) were prescribed psychotropic medication in 
2014. More antidepressants (52%, n=833) and hypnotics/
sedatives (38%, n=614) were prescribed than anxiolytics 
(13%, n=202). During the follow-up in 2014, eight employees 
died, and four of these deaths occurred before a psychotropic 
prescriptions (censoring).
Table 2 shows that any organisational changes in 2013 was 
associated with an HR of 1.14 (95% CI: 1.02 to 1.26) for 
psychotropic prescriptions in 2014 relative to no changes. 
Medical doctors/dentists and employees aged 56–75 had partic-
ularly high HRs of psychotropic prescriptions. As reflected by 
the ICC, the correlation of psychotropic prescriptions between 
work units explained 6% of the total variation in psychotropic 
prescriptions. This indicates that work units are an important 
contributor to prescriptions for psychotropic medication among 
employees. Adjustment for employee and work-unit level covari-
ates led to slightly higher HR of psychotropic prescriptions after 
any changes. Additional adjustment for potential confounding 
by prior psychotropic prescriptions in this model attenuated the 
association (HR: 1.08, 95% CI: 0.97 to 1.20).
Following any organisational changes, there was a higher rate 
ratio for prescription of antidepressants (HR: 1.21, 95% CI: 
1.05 to 1.40) and indications of a higher rate ratio for prescrip-
tion of anxiolytics (HR: 1.25, 95% CI: 0.93 to 1.69), but no 
association for prescription of hypnotics/sedatives (HR: 1.00, 
95% CI: 0.85 to 1.19).
We only found weak indications of an additive interaction 
between any changes and females (S: 1.36, 95% CI: 0.32 to 
5.84; supplementary material 5) and no multiplicative interac-
tions (p=0.69). This indicates no differential effects of organisa-
tional changes regarding sex.
In table 3, the fully adjusted model 4 shows that change in 
management in 2013 was associated with a HR of 1.23 (95% 
CI: 1.07 to 1.41) for psychotropic prescriptions in 2014 rela-
tive to no changes. This excess HR of psychotropic prescriptions 
remained in a sample excluding all managers (n=14 040; HR: 
1.24, 95% CI: 1.07 to 1.42), indicating that the effect was not 
attributable to managers laid off. There were indications of higher 
prescription rates after mergers, employee lay-off or budgets 
cuts, but these findings were not statistically significant. Indeed, 
employee lay-off and budget cuts were statistically significantly 
associated with a higher rate of psychotropic prescriptions in 
model 3 adjusted for age, sex and socio-occupational factors. 
However, these effects attenuated in model 4 when additionally 
adjusting for mergers, change in management and budget cuts as 
confounders on the association between employee lay-offs and 
psychotropic prescriptions.
Table 4 presents the rate ratios of psychotropic prescriptions 
splitting the 12-month follow-up period into two halves. In 
the former follow-up period, only change in management was 
associated with a higher rate of psychotropic prescriptions. In 
the second period, exposure to any changes, mergers, change 
in management, employee lay-off or budget cuts were statisti-
cally significantly associated with a 1.19–1.42 times higher rate 
of psychotropic prescriptions relative to no change. Any changes 
occurring in the former and latter semester of 2013 were simi-
larly associated with excess rates of psychotropic prescriptions 
through 2014 (HR: 1.11, 95% CI: 0.99 to 1.24 and HR: 1.16, 
95% CI: 1.04 to 1.29, respectively), suggesting a comparable 
effect of the exposure on outcome over time. There were no 
meaningful differences between prescription rates following 
exposure to 1, 2 or 3≤ types of simultaneous changes relative to 
no change in either half follow-up period, indicating no cumula-
tive effects by multiple changes (data not shown).
dIsCussIOn
More than half of the studied employees were exposed to organ-
isational changes. We found higher risk of prescriptions for 
psychotropic medication among employees in the year after they 
remained in the work unit during any organisational changes 
compared with no changes. This association was particularly 
strong following change in management and in relation to 
prescription of antidepressants. Splitting the follow-up period 
into two halves yielded a stronger association in the latter half 
of the 12-month follow-up compared with the former half, indi-
cating a latency period before an increase in prescriptions. The 
observed association did not vary according to sex.
Our findings of a 1.09-fold and 1.25-fold higher rate ratio 
of psychotropic prescriptions in the former and the latter 
halves of the year after any changes, respectively, corroborate 
with prior findings from another Danish study of a 1.09-fold 
higher rate of psychotropic prescriptions which was stron-
gest in the year immediately after the changes.25 In our study, 
this association was particularly strong for change in manage-
ment which, to our knowledge, has not been reported before. 
Among both men and women, we found a roughly 1.15-fold 
higher rate over the 12-month follow-up which is comparable 
with the Finnish 10-Town study estimate of a 1.12 times higher 
rate of psychotropic drug prescription after major downsizing 
among women. In that same study, the prescription rates were 
notably higher among male employees (1.49),22 whereas in our 
study the interaction analyses yielded no sex differences in line 
with other studies.23 24 In fact, sex did not predict psychotropic 
prescriptions significantly in the present study. This could be due 
to limited statistical power since only 357 (2%) male employees 
were prescribed psychotropic medications during follow-up. 
Also, we found no cumulative effects of exposure to multiple 
changes (1, 2 or 3≤) which contradicts previous findings of 
comprehensive changes being particularly associated with excess 
risk of psychotropic prescriptions.25 This may be explained by 
excess employee turnover rates during a greater number simulta-
neous changes as indicated by a prior study.5
Adjusting the association between changes and psychotropic 
prescriptions during 2014 for prior psychotropic prescriptions 
between 2011 and 2012 attenuated the HR from 1.14 to 1.08; 
however, this reduction towards the null may be explained by 
the introduction of an index event bias36 as episodes of mental 
disorders are highly recurrent in a workplace context.37 Index 
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Table 2 HR of prescription for psychotropic medication in 2014 (n=1616) among the study population (n=15 038)
Fixed part
Prescription, follow-up 1 January to 31 december 2014
Model 1 Model 2 Model 3
Hr 95% CI Hr 95% CI
Work-unit level variables (level 2)
Any organisational changes* 1.13 1.02 to 1.26 1.14 1.02 to 1.26
Number of employees within work unit†
  13–22 1.00 0.86 to 1.15
  23–32 0.95 0.81 to 1.10
  33–142 0.82 0.70 to 0.96
Individual-level variables (level 1)
  Age group‡
   40–48 1.41 1.19 to 1.69
   48–56 1.68 1.40 to 2.00
   56–75 2.09 1.73 to 2.51
  Male§ 0.88 0.77 to 1.02
  Occupational group¶
   Medical doctors/dentists 2.33 1.85 to 2.88
   Social/healthcare workers 0.95 0.80 to 1.13
   Pedagogical workers 0.89 0.63 to 1.25
   Service/technical workers 0.94 0.77 to 1.16
   Administrative workers 1.17 1.00 to 1.35
  Seniority, years**
   5–10 1.10 0.94 to 1.28
   11–20 1.00 0.85 to 1.19
   ≥21 0.99 0.82 to 1.19
   Manager, yes†† 0.97 0.79 to 1.21
  Weekly working hours‡‡
   32–37 1.00 0.85 to 1.17
   ≥37 0.77 0.68 to 0.88
  Contractual employment, yes§§ 1.00 0.82 to 1.22
  Personal gross income, DKK¶¶
   345 000–400 000 0.90 0.79 to 1.04
   400 001–480 000 0.85 0.72 to 0.98
   ≥480 001 0.86 0.71 to 1.03
  Sickness absence in 2012, days***
   1–3 0.91 0.77 to 1.07
   4–6 1.20 1.01 to 1.42
   7–13 1.52 1.30 to 1.78
   ≥14 2.33 2.01 to 2.70
random part
ICC (p value), work-unit level (level 2) 0.06 (<0.01) 0.05 (<0.01) 0.02 (0.13)
Model 1: Null model with a random intercept for the work-unit level. Model 2: As model 1, but the ‘Any changes’ variable in the fixed part. Model 3: As model 2, but effects of the 
‘Any changes’ variable were fully adjusted for all employee-level covariates and number of employees within the work unit.
Reference categories
  *No change; †3–12 employees within the work unit; ‡age group 19–40; §female; ¶nurses; **1–4 seniority years; ††not manager; ‡‡18.5–32 weekly working hours; §§no 
contractual employment; ¶¶personal gross income ≤345 000 DKK; ***no days of sickness absence in 2012.
DKK, Danish Krone; ICC, intraclass correlation coefficient.
event bias refers to the selection of participants based on index 
events (prior prescriptions) for whom the putative risk factor 
(changes) is associated with an observed lower probability of 
new events (new prescriptions). Conditioning on prior psycho-
tropic prescriptions could actually ‘protect’ against new psycho-
tropic prescriptions as associated with organisational changes 
because employees with mental illness would likely adapt their 
working life according to their limited occupational capacity (eg, 
not working full-time) which thus induces dependence between 
otherwise independent confounder variables. In support to this 
perspective, the descriptive statistics indicated no confounding 
by prior psychotropic prescriptions, and the proportion of full-
time employees was in fact smaller among those with prior 
psychotropic prescriptions (53% of n=2049) than employees 
without prior prescriptions (59% of n=12 989).
It has previously been highlighted that adverse effects of 
organisational changes at the workplace are primarily driven 
by changes in job insecurity among employees.38 This is in line 
with findings of excess psychotropic prescription rates after 
change in management or employee lay-off as such changes may 
elevate uncertainty about future employment and new down-
sizing waves in the work unit. In addition, mergers were also 
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Table 3 HR of prescription of psychotropic medication in 2014 (n=1616) according to each type of organisational changes in 2013 among the 
study population (n=15 038)
Prescription, follow-up 1 January to 31 december 2014
Model 3 Model 4
n (% prescriptions) Hr 95% CI Hr 95% CI
No changes 6796 (10.1) 1.00 1.00
Mergers 2560 (11.4) 1.11 0.95 to 1.28 1.14* 0.97 to 1.34
Split-ups 956 (10.2) 0.98 0.79 to 1.23 0.98† 0.78 to 1.23
Relocation 1872 (10.3) 1.00 0.85 to 1.19 1.02‡ 0.84 to 1.24
Change in management 3781 (12.1) 1.19 1.05 to 1.35 1.23‡ 1.07 to 1.41
Employee lay-off 3204 (11.8) 1.20 1.05 to 1.38 1.15§ 0.98 to 1.35
Budget cuts 2401 (11.6) 1.15 1.00 to 1.34 1.12¶ 0.95 to 1.31
Results for covariates omitted as no noteworthy changes in estimates were observed relative to table 2.
Model 3: Each type of change indicator adjusted for all employee-level covariates and number of work-unit employee and in the fixed part and a random intercept for the work-
unit level. Model 4: As model 3, but each type of organisational changes additionally adjusted for other changes as potential confounders on the association with psychotropic 
prescriptions:
*Split-ups and Budget cuts; †budget cuts; ‡mergers and Split-ups; §mergers, change in management and budget cuts; ¶change in management.
Table 4 HR of prescription for psychotropic medication in the former period from January to June 2014 or in the latter period from July to 
December 2014 according to organisational changes in 2013 among the study population (n=15 038)
n
Prescription, follow-up
1 January to 30 June 2014
Prescription, follow-up
1 July to 31 december 2014
Fully adjusted model Fully adjusted model
Prescriptions 
(n=1257), % of n Hr 95% CI
Prescriptions 
(n=1268), % of n Hr 95% CI
No changes 6796 8.0 1.00 7.5 1.00
Any changes 8242 8.6 1.09 0.97 to 1.22 9.3 1.25 1.11 to 1.41
Mergers 2560 8.2 1.05* 0.88 to 1.26 9.3 1.26* 1.06 to 1.50
Split-ups 956 7.2 0.87† 0.67 to 1.14 7.9 1.02† 0.79 to 1.31
Relocation 1872 7.8 1.02‡ 0.82 to 1.28 8.6 1.16‡ 0.93 to 1.44
Change in 
management
3781 9.2 1.20‡ 1.03 to 1.41 10.3 1.42‡ 1.22 to 1.65
Employee lay-off 3204 9.0 1.16§ 0.97 to 1.39 9.6 1.23§ 1.03 to 1.46
Budget cuts 2401 8.5 1.04¶ 0.87 to 1.24 9.5 1.19¶ 1.00 to 1.41
Results for covariates omitted as no noteworthy change in estimates were observed relative to table 2.
Fully adjusted model: ‘Any changes’ adjusted for all employee-level covariates and number of work-unit employee and in the fixed part and a random intercept for the work-unit 
level (model 3). Each type of organisational changes additionally adjusted for other changes as potential confounders on the association with psychotropic prescriptions:
*Split-ups and budget cuts; ‡budget cuts; ‡mergers and split-ups; §mergers, change in management and budget cuts; ¶change in management (model 4).
associated with an excess rate of psychotropic prescriptions in 
the latter half of the 12-month follow-up period which could be 
hypothetically explained by subsequent reduction in redundant 
staff following mergers. We had, however, no data on changes 
during follow-up to test this. Adverse effects of organisational 
changes are also previously found to be mediated by changes in 
job strain.39 Hence, long-term changes in job strain may explain 
why the excess rate ratios of psychotropic prescriptions were 
observed to be stronger in the latter period of follow-up than 
the earlier period immediately following organisational changes. 
Managers have a key role in organising work, and a change in 
management may follow increased demands in work procedures 
(eg, excess work documentation) inducing further psychosocial 
repercussions among employees. In addition, demands of work-
unit productivity may not be adjusted to the staff composition 
after employee lay-offs which could lead to workload intensifi-
cation among the remaining employees.
strengths and limitations
The associations found in the present study may be underes-
timated because we were unable to adjust for organisational 
changes occurring during the 12-month follow-up on psycho-
tropic prescriptions. Neither did we assess the effects on 
psychotropic prescriptions during or before the observation of 
organisational changes in 2013. It is, however, reasonable to 
assume that the majority of employees prescribed psychotropic 
medication in 2013 would extend their medical treatment into 
the follow-up period in 2014. Indeed, if an employee exited the 
work unit during 2013 (eg, due to common mental disorder), 
the participant would not be included in the study population. 
Data on changes in 2013 obtained from managers 3 years later 
may be influenced by recall bias; however, since the managers 
most likely executed the changes, this bias is considered minor. 
Finally, using composite change measures for 2013 limits conclu-
sions on the duration of the latency period.
This study benefited from assessing the relative impact of 
various and frequently occurring types of organisational changes. 
These changes were measured at the work-unit level among 
employees who remained in the work unit during the observa-
tion of the changes. This approach ensured that the employees 
personally experienced the changes. Assessing various types of 
changes also allowed us to create a purer reference group not 
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exposed to any of these changes as opposed to previous studies 
focusing on a single type of change. In addition, the nesting of 
employees within work units enabled us to adjust for clustering 
within work units. It was also a strength of the study that we 
used independent data sources hampering bias due to common 
variance regarding the exposure and outcome variables. Finally, 
data on psychotropic prescriptions were extracted from highly 
reliable national registers adding to the validity of the findings.
More research and practitioner attention should be devoted 
to the temporality in adverse effects of specific change types 
since mental health effects may develop over an extended period 
following the change event. The present study has highlighted 
change in management as a particular risk factor for employee 
mental health, and elucidating the underlying psychosocial 
mechanisms on this longitudinal association is an objective for 
future studies.
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